Human rhinovirus and coronavirus detection among allogeneic hematopoietic stem cell transplantation recipients
Open Access
- 11 March 2010
- journal article
- Published by American Society of Hematology in Blood
- Vol. 115 (10), 2088-2094
- https://doi.org/10.1182/blood-2009-09-244152
Abstract
Little is known about clinical and virologic manifestations of rhinovirus (HRV) and coronavirus (HCoV) infections after hematopoietic cell transplantation (HCT). We performed surveillance for 1 year and describe the natural history of these infections during the first 100 days after allogeneic HCT, when symptom surveys and upper respiratory samples were collected weekly. Samples were tested using RT-PCR for HRVs and HCoVs (OC43, 229E, HKU1, and NL63). Among 215 patients, 64 (30%) patients had 67 infections. Day 100 cumulative incidence estimate was 22.3% for HRV and 11.1% for HCoV. Median duration of viral shedding was 3 weeks; prolonged shedding of at least 3 months occurred in 6 of 45 patients with HRV and 3 of 22 with HCoV. Six patients with HRV and 9 with HCoV were asymptomatic. HRV infection was associated with rhinorrhea, congestion, postnasal drip, sputum, and cough; HCoV infection was not associated with respiratory symptoms or hepatic dysfunction. Lower respiratory infection developed in 2 patients with HRV before day 100, and 1 each with HRV and HCoV after day 100. HRV and HCoV infections are common in the first 100 days after HCT, viral shedding lasts more than 3 weeks in half, and lower respiratory infection is rare.This publication has 35 references indexed in Scilit:
- Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infectionBlood, 2007
- CORONAVIRUS-ASSOCIATED PNEUMONIA IN PREVIOUSLY HEALTHY CHILDRENThe Pediatric Infectious Disease Journal, 2007
- Two Outbreaks of Severe Respiratory Disease in Nursing Homes Associated with RhinovirusJournal of the American Geriatrics Society, 2005
- Prospective Study of the Incidence, Clinical Features, and Outcome of Symptomatic Upper and Lower Respiratory Tract Infections by Respiratory Viruses in Adult Recipients of Hematopoietic Stem Cell Transplants for Hematologic MalignanciesTransplantation and Cellular Therapy, 2005
- Influenza Infections after Hematopoietic Stem Cell Transplantation: Risk Factors, Mortality, and the Effect of Antiviral TherapyClinical Infectious Diseases, 2004
- Rhinovirus and Coronavirus Infection–Associated Hospitalizations among Older AdultsThe Journal of Infectious Diseases, 2002
- Community-acquired respiratory syncytial virus and parainfluenza virus infections after hematopoietic stem cell transplantation: The Fred Hutchinson Cancer Research Center experienceTransplantation and Cellular Therapy, 2001
- Parainfluenza virus infections after hematopoietic stem cell transplantation: risk factors, response to antiviral therapy, and effect on transplant outcomeBlood, 2001
- Adenovirus Infections in Adult Recipients of Blood and Marrow TransplantsClinical Infectious Diseases, 2001
- Community Respiratory Virus Infections Among Hospitalized Adult Bone Marrow Transplant RecipientsClinical Infectious Diseases, 1996